Fusion Pharmaceuticals In...

NASDAQ: FUSN · Real-Time Price · USD
21.55
0.03 (0.14%)
At close: Jun 03, 2024, 10:00 PM

Fusion Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-6.64 -1.57 -2.19
PEG Ratio
0.24 -0.3 0.05
PS Ratio
304.90 94.32 123.36
PB Ratio
2.83 0.85 0.77
P/FCF Ratio
-7.36 -1.83 -2.3
P/OCF Ratio
-7.71 -1.88 -2.35
OCF/S Ratio
-39.56 -50.15 -52.6
Debt / Equity Ratio
0.23 0.25 0.03
Quick Ratio
15.01 12.54 16.10
Current Ratio
15.01 11.88 16.93
Asset Turnover
0.01 0.01 0.01
Interest Coverage
-19.21 -48.88 n/a
Return on Equity
-0.43 -0.54 -0.35
Return on Assets
-0.33 -0.4 -0.32
Return on Invested Capital
-0.37 -0.42 -0.34
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
0.35 -39.31 -38.14
Net Profit Margin
-45.89 -59.97 -56.28
Pretax Profit Margin
-45.51 -61.22 -56.36
Operating Profit Margin
-47.98 -60.26 -56.95
FCF Margin
n/a n/a n/a
EBITDA Margin
-47.33 -59.99 -56.51